Page last updated: 2024-08-26

paxilline and Carcinoma, Transitional Cell

paxilline has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baffa, R; Gomella, LG; Gonzalez, EM; Hellman, M; Iozzo, RV; Monami, G; Morrione, A	1

Other Studies

1 other study(ies) available for paxilline and Carcinoma, Transitional Cell

Article	Year
Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer research, 2006, Jul-15, Volume: 66, Issue:14 Topics: Carcinoma, Transitional Cell; Cell Movement; Enzyme Activation; Focal Adhesion Kinase 1; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Paxillin; Progranulins; Protein Precursors; Recombinant Proteins; Urinary Bladder Neoplasms	2006

Article

Year

Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.

Cancer research, 2006, Jul-15, Volume: 66, Issue:14

Topics: Carcinoma, Transitional Cell; Cell Movement; Enzyme Activation; Focal Adhesion Kinase 1; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Paxillin; Progranulins; Protein Precursors; Recombinant Proteins; Urinary Bladder Neoplasms

2006